Sign inJoin waitlistJoin the waitlist

Amber Podoll

Associate Professor, Renal Diseases and Hypertension · University of Texas Health Science Center at Houston

Credentials: · · · · · ·

History

University of Texas Health Science Center at Houston
Present

Nephrology
University of Texas Health Science Center at Houston
2006–2008
Internal Medicine
Baylor College of Medicine
2003–2006
Ohio State University College of Medicine
1998–2002
California Polytechnic State University, San Luis Obispo
1994–1998

Research

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
Arthritis & Rheumatology · 2021 · 163 citations
Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort
PLoS ONE · 2012 · 69 citations
Complications of continuous renal replacement therapy
Review · Seminars in Dialysis · 2009 · 62 citations

Kevin Finkel
12 papers
Carl Walther
3 papers · 3 as a fellow
Ala Abudayyeh
1 paper
AG
Aleksandra De Golovine
1 paper
Amit Saxena
1 paper
Anca Askanase
1 paper
Andrew Bomback
1 paper
AR
Arun Rajasekaran
1 paper · 1 as a resident
Betty Diamond
1 paper
BM
Brad Marder
1 paper
Brad Rovin
1 paper
CA
Cynthia Aranow
1 paper

Clinical trials

VIBRANT: VIB4920 for Active Lupus Nephritis
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2022–2028
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2022–2028
Belimumab With Rituximab for Primary Membranous Nephropathy
Site PI · Recruiting · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2020–2030
Nephrotic Syndrome Study Network
Site PI · Recruiting
University of Michigan
2010–2030